Weekly CEO Buys Highlight
- By Joy Hu
According to GuruFocus Insider Data, these were the largest CEO buys during the past week.
Carriage Services
Carriage Services Inc. (NYSE:CSV) CEO Melvin C. Payne bought 29,000 shares on Dec. 9 at a price of $30.02. The price of the stock has decreased by 1.03% since then.
Carriage Services is a leading provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: the Funeral Home Operations segment, which offers burial, cremation, consultation and other services; and the Cemetery Operations segment, which provides services such as mausoleum crypts, private estates, lawn crypt gardens, traditional single burial gravesites and burial vaults.
The company has a market cap of $533.88 million. Its shares traded at $29.71 with a price-earnings ratio of 52.03 as of Dec. 11.
Net income for the third quarter of 2020 was $5.5 million.
Cannae Holdings
Cannae Holdings Inc. (NYSE:CNNE) CEO Richard N. Massey bought 15,000 shares on Dec. 8 at a price of $42.33. Since then, the price of the stock has increased by 0.45%.
Cannae Holdings is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant group, Ceridian, T-System, Dun & Bradstreet, Corporate and other.
The company has a market cap of $3.90 billion. Its shares traded at $42.52 with a price-earnings ratio of 2.71 as of Dec. 11.
Net loss for the quarter ended Sept. 30, 2020 was $14.9 million.
Golub Capital BDC
Golub Capital BDC Inc. (NASDAQ:GBDC) CEO David Golub bought 7,961 shares during the past week at the average price of $14.08.
Golub Capital BDC is an externally managed, closed-end, non-diversified investment management company. The company's investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in U.S. middle-market companies. It also invests in second lien and subordinated loans, warrants and minority equity securities in middle-market companies.
The company has a market cap of $2.3 billion. Its shares traded at $13.75 with a price-earnings ratio of 37.36 as of Dec. 11.
Net investment income during the three months ended Sept. 30 was $39.31 million.
Golub bought 4,000 shares on Nov. 27 at a price of $14.01; 3,755 shares on Dec. 1 at a price of $13.99; 4,000 shares on Dec. 2 at a price of $14.09; 3,961 shares on Dec. 7 at a price of $14.09; and 4,000 shares on Dec. 9 at a price of $14.08. The price of the stock has decreased by 2.34% since then.
Chairman Lawrence E. Golub bought 4,000 shares on Nov. 27 at a price of $14.01; 3,755 shares on Dec. 1 at a price of $13.99; 4,000 shares on Dec. 2 at a price of $14.09; 3,961 shares on Dec. 7 at a price of $14.09; and 4,000 shares on Dec. 9 at a price of $14.08. Since then, the price of the stock has decreased by 2.34%.
Chinook Therapeutics
Chinook Therapeutics Inc. (NASDAQ:KDNY) President and CEO Eric Dobmeier bought 4,000 shares on Dec. 9 at a price of $13.16. The price of the stock has increased by 1.22% since then.
Chinook Therapeutics is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases. The products of the company are focused on rare, severe chronic kidney disorders.
The company has a market cap of $561.55 million. Its shares traded at $13.32 as of Dec. 11.
Net loss for the third quarter of 2020 was $14.54 million.
Dobmeier also bought 2,000 shares on Nov. 23 at a price of $13.63. Since then, the price of the stock has decreased by 2.27%.
For the complete list of stocks bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
This article first appeared on GuruFocus.